[go: up one dir, main page]

WO2002056121A2 - Systemes de poursuite d'echantillons - Google Patents

Systemes de poursuite d'echantillons Download PDF

Info

Publication number
WO2002056121A2
WO2002056121A2 PCT/GB2001/005578 GB0105578W WO02056121A2 WO 2002056121 A2 WO2002056121 A2 WO 2002056121A2 GB 0105578 W GB0105578 W GB 0105578W WO 02056121 A2 WO02056121 A2 WO 02056121A2
Authority
WO
WIPO (PCT)
Prior art keywords
sample
data
chip
memory chip
specific data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/005578
Other languages
English (en)
Other versions
WO2002056121A3 (fr
Inventor
Paul Schmidt
Kobus Preller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU2001297886A priority Critical patent/AU2001297886A1/en
Publication of WO2002056121A2 publication Critical patent/WO2002056121A2/fr
Publication of WO2002056121A3 publication Critical patent/WO2002056121A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/117—Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/15003—Source of blood for venous or arterial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150763—Details with identification means
    • A61B5/150793—Electrical or magnetic identification means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150847—Communication to or from blood sampling device
    • A61B5/150854—Communication to or from blood sampling device long distance, e.g. between patient's home and doctor's office
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B19/00—Programme-control systems
    • G05B19/02—Programme-control systems electric
    • G05B19/04—Programme control other than numerical control, i.e. in sequence controllers or logic controllers
    • G05B19/12—Programme control other than numerical control, i.e. in sequence controllers or logic controllers using record carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08—Sensors provided with means for identification, e.g. barcodes or memory chips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150389—Hollow piercing elements, e.g. canulas, needles, for piercing the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150503—Single-ended needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/153—Devices specially adapted for taking samples of venous or arterial blood, e.g. with syringes
    • A61B5/154—Devices using pre-evacuated means
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/30—Nc systems
    • G05B2219/31—From computer integrated manufacturing till monitoring
    • G05B2219/31095—Read write intelligent chip on workpiece, pallet, tool for data exchange
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/30—Nc systems
    • G05B2219/31—From computer integrated manufacturing till monitoring
    • G05B2219/31162—Wireless lan
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/30—Nc systems
    • G05B2219/33—Director till display
    • G05B2219/33192—Radio link, wireless
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/30—Nc systems
    • G05B2219/45—Nc applications
    • G05B2219/45092—Analysing or chemical synthesis robot, moving samples from station to station

Definitions

  • the present invention relates to a method of tracking and controlling the passage of a sample through a test procedure. It relates also to the capture, transfer, manipulation, and storage of data related to the sample. It further relates to a sample carrier acting as a data conveyance tool for use in such a system. It still further relates to methods of associating such data with a sample when loading into a carrier for use in such a system.
  • the invention finds a particular application in the medical field, but it will be appreciated that its use is not limited thereto.
  • Testing often needs to be performed on a variety of samples provided from one or a number of locations. Such testing frequently requires the sample to be sent to a laboratory, which performs a test procedure or procedures on samples from a variety of origins. It is vital that the tests are correctly associated with the original source of the sample (for example a patient), that samples are correctly collected and transported to where they will be analysed and then subjected to the correct testing. It is further vital that results are correctly reconciled with other data associated with the original source of the sample and that the results are delivered to the correct users of the data. The only practical way to even try to achieve this, before now, has involved complex paper-based logging systems and the need for suitable documentation to accompany the sample when it is supplied to the test lab.
  • the present invention will find particular application in the field of medical testing which is performed in clinical laboratories, hospitals, medical practices and surgeries, and particular problems associated therewith will be discussed herein.
  • the present invention is equally applicable to other sample testing situations, especially where the originator does not perform the tests.
  • the testing laboratories are often located at geographically separate facilities that serve a number of hospitals and/or doctors' surgeries.
  • Medical staff, such as doctors rely on the results of various testing procedures to make a diagnosis, to determine the appropriate treatment strategy, and to monitor a patient's condition. It is essential that a sample is correctly associated with a patient and the person making the testing request (hereinafter also referred to as a requestor) (e.g. a doctor).
  • locator information such as the hospital or ward name
  • the correct request and collection time and the identity of the sample collector (or sampler) is recorded and that the correct test is performed on that sample.
  • the requestor may also need to indicate to the laboratory the speed that the results are required to effectively treat a patient.
  • a sampler has to associate a sample that has been labelled with identifying key information, and supply a completed request form containing identical key information and other information required to process the sample. Both these items are then sent to the lab where a laboratory identifier system allocates an additional key to the sample and the form. This key is then used to maintain the association between the sample and the request form for when the sample is separated from the form to allow the sample to be analysed. The information on the request form is then manually entered into the laboratory system in association with the laboratory key. After the sample has been processed by the analyser, the laboratory key is required to reconcile the request and test result data.
  • the data on the original request form and the laboratory information system is re-checked for data entry errors.
  • the results are then returned to the hospital ward or doctor's practice. There are significant delays associated with completion of the request, processing of the sample and delivery of the results. Once results are returned, the requestor will have to collect them from the place to which they were returned (such as a hospital information system or medical record). Such a step is a time consuming inconvenience for busy medical staff.
  • sample carrier having an addressable non-volatile memory chip to which data may be stored and from which said data may be retrieved electronically using wireless transmission
  • the person requesting the test results is herein generally referred to as the requestor.
  • the requestor may also be the sampler or may be a different person.
  • sample specific data may include an identifier, which may be a code linked to the other data or may actually be derived from patient data recorded onto the chip pre-analytically (i.e. before it reaches the lab).
  • an identifier key may be imparted by the laboratory control system on arrival of the sample at the testing location. This laboratory identifier key may be used by the laboratory control system to trace and control the progress of the testing.
  • the steps of introducing the sample carrier to testing apparatus; reading the sample specific data; writing the laboratory key to the chip; performing appropriate processing, sorting, channelling and/or test procedures; loading details concerning the test results and the completion thereof onto the memory chip; and supplying details to the requestor; are controlled by a computerised laboratory control system.
  • the data carried on the memory chip is important. To meet the objectives of the present invention it is important that the information allows the results of the testing to be accurately recorded and returned to the requestor and associated correctly with the origin of the sample (e.g. a specific patient).
  • the possible data elements comprising the sample specific data could include:
  • a carrier type identifier e.g. identifies different types of test tube containing chemicals that enable certain tests. This is usually coded onto the sample memory chip on manufacture of the sample carrier
  • a sample type identifier e.g. blood, urine etc.
  • Patient data e.g. name, age, sex, code number
  • the carrier class identifier mentioned above could be encoded during manufacturing of the carrier.
  • the carrier class identifier could follow the ISO standard for test tube types so that all tubes have a consistent labelling system (Reference number ISO 6710:1995 (E)).
  • E reference number ISO 6710:1995 (E)
  • a full blood count carrier could have 1 as it's unique identifier and a glucose carrier could have 2 as the identifier. This would allow the person loading the sample into the carrier to automatically associate only the correct test requests with the specific carrier, easing the task of deciding which test request goes with a sample.
  • a second important role of the carrier type identifier is in the laboratory where it will facilitate automated sorting of sample carriers rather than human action.
  • the 3 variables required on the test tube memory chip for an intended sorting algorithm are: type of carrier, test type requested, and urgency of the request (prioritisation).
  • identifier may be loaded as a laboratory code onto the memory chip when the sample arrives in the laboratory. This allows labs to continue with the tracking code systems they already use, the present invention could simply interface with the existing lab control system with only minor modification thereof.
  • an identifier unique to the requestor - such as a network address or Internet Protocol (IP) address - could be imparted to the memory chip.
  • IP Internet Protocol
  • This locator may be the physical address of the device being used to program the chip, but would more likely be a "pointer" or "mailbox" address on the network or Internet that relays the message further according to a set of rules specified.
  • this is known as a multicast IP address. This would allow results from tests performed on the specific sample to be returned to the mobile programming device that the originator used to conduct the work or perhaps to a personal mailbox on the network specified for the user that can flag up the availability of the result the next time the user logs on, thereby saving time and effort to look up the result.
  • the memory chip will also be programmed with information that could modify this reporting function depending on: 1. The urgency that results of tests performed on the sample are required; and, 2. The person that took the sample. If, for example, a laboratory phlebotomist took the sample, it would not be appropriate for the result to be returned to the phlebotomist ("sampler"), but should instead be returned to the responsible physician ("requestor").
  • One of the important features of the present invention is that all data required to process the sample may be provided on the chip, so making the system "network independent" - there should be no need for the laboratory control system to reference the requestor's database to link or retrieve data elements. However a link to such a database may be provided for verification or other purposes.
  • the initial process of getting the information from the memory chip into the testing apparatus or laboratory control system preferably involves reading the sample specific data from the chip, updating the laboratory database (part of a laboratory control system) with the data, associating a laboratory number with the sample specific data, and writing this laboratory number onto the memory chip.
  • Most patient databases whether GP or hospital based, usually allocate a database number to a patient. Knowing the origin of the sample and a unique patient number within a database at the origin means a result can be accurately returned to the originator's database. Also there is increasingly within many countries a movement towards national unique patient identifiers, which could be used instead to identify the patient.
  • a further good reason to put all patient demographic or identifying data on the memory chip is that it allows the laboratory control system to make automatic comparisons to the normal values expected based on sex, age or other demographic data of the patients and therefore allow automatic authorisation of results.
  • Currently only a few laboratories in Europe have bi- directional interfacing between the hospital information system and the laboratory control system to allow this feature to be implemented. Including the information on the chip obviates the need for such a link, which can be expensive to implement, whilst still providing the benefits.
  • the sample carrier and contained sample could first be introduced to a registering apparatus.
  • a registering apparatus could be a memory chip reading/writing transponder linked to the laboratory control system. This could be operated by a human worker, or preferably by an automated carrier sorter with an embedded transponder.
  • An additional class of information that could be recorded onto the chip are instructions recorded in the lab during processing that inform "downstream" machines what should be done with the sample.
  • a good example could include that an instruction be added to ensure that a single sample be split, or that a number of daughter samples be prepared, or that the contents be deposited in or on a different container such as a culture flask (virology), petri-dish (microbiology), DNA array chip (genomics), micro-titre plate (immunology/serology), or glass slide (cytology/histology).
  • a sample or part thereof is transferred to a new carrier the data stored on the memory chip of the original sample could be transferred to the new carrier, and both could be augmented with data that allows tracking of the transfer event. In other instances it may simply be the identifying data, not the contents of the carrier vessel that should be transferred securely such as during preparation of blood products that have to be cross matched for blood transfusion. In this way an unbroken chain of "positive identification" is obtained without human intervention.
  • kits could pertain to variables found during testing, such as volume of the blood sample, which may influence testing temperature control, incubation times or subdivision of the sample.
  • Other uses envisaged are that blood that is obtained from a blood donor is tested for various pathogens such as hepatitis B or HIV and cross-matched. The results from those tests are imprinted on the chip to serve as a "certificate" of quality and origin (to counter uncontrolled sources of blood).
  • the carrier would comprise a blood bag provided with a memory chip
  • sample specific data onto the chip may be performed by a requestor, or may be done by a sampler specifically tasked with taking the sample and despatching it to the test environment.
  • a doctor the requestor
  • the sample specific data could also include the date/time of both requesting and sampling.
  • a personal data programmer or personal digital assistant [PDA]
  • PDA personal digital assistant
  • personal digital assistants generally comprise a processor, display, data entry means such as a keyboard, and software applications running thereon.
  • the personal data programmer may be capable of reading and programming the chip and also able to communicate with a central database when present.
  • Many commercially available products could be used if provided with the appropriate transceiver or transponder and control software.
  • the personal data programmer could interface with a local computer so as to transmit or store data.
  • the personal data programmer could communicate directly with the laboratory control system or central database, for example using a mobile phone connection, wireless network or radio frequency communication.
  • Patient specific data such as date of birth, sex, name, address, and GP or hospital database numbers should go on the memory chip. As discussed before this removes the need for a central reference database, even though one may still be used. For example, in the UK a GP practice nurse have need to obtain a blood sample from a patient at home. In the process he/she could label the blood sample with patient specific information from a personal digital assistant which could contain a database of all patients registered with a GP, or instead the information could be input de novo into the personal digital assistant at the patient's home and the test tube be labelled with the information.
  • the testing apparatus is at least partially automated.
  • the transport mechanisms that carry the sample carrier, and/or the testing equipment themselves could be automated. Control of such systems would generally be integrated within the laboratory control system.
  • results When the results are returned to a user it may be preferred that he is notified immediately if for example the requestor had prioritised the sample as URGENT or EMERGENCY.
  • the results may be passively received by the requestor by means of their being sent by some form of electronic delivery system such as e-mail, SMS text messaging, or direct to the software on the personal data programmer.
  • some form of electronic delivery system such as e-mail, SMS text messaging, or direct to the software on the personal data programmer.
  • the locator on the memory chip needs to include some physical address such as a network address or Internet Protocol (IP) address.
  • IP Internet Protocol
  • the data in the database could be actively obtained by the user accessing the database to view the information. This would remove the need for the sample specific data to include a complete return locator or address, but might instead need it to have security or other access controlling information.
  • Communication between the database and the user could utilise any suitable communication network such as the Internet, Wide area network (WAN) or local area network (LAN).
  • WAN Wide area network
  • LAN local area network
  • the personal data programmer can interface with any local database that provides information on the origin of the sample.
  • any computerised details held concerning the patient could be provided to the personal data programmer for loading onto the data chip.
  • the personal data programmer could interrogate the hospital's information systems, perhaps through wireless communication.
  • information on the patient could be provided on patient tags having addressable tagging chips similar to the memory chip included on the sample carrier.
  • patients are provided with patient tags which would carry addressable tagging chips to store patient specific information.
  • This information could be read in a similar way to the memory chip on the sample carrier by the personal data programmers prior to programming sample specific data onto the memory chip.
  • a requestor could load details of samples to be taken on the tagging chip.
  • a sampler could then read the tagging chip to discover what samples to take and what tests to order, as well as retrieving the patient data to program the sample specific data.
  • the sample As the sample is tested in the laboratory or otherwise, details of the test results are loaded onto the memory chip and are also provided to the database or laboratory control system. To correlate the data and check for discrepancies, it is preferred that an additional step is performed wherein the data stored on the memory chip is compared to that on the laboratory control system (or central database if present). The data stored on the lab control system and that stored on the memory chip may then be compared after completion of each or all test procedures. If any discrepancies are found between the test data on the memory chip and in the database the sample may be returned to the test apparatus to undergo appropriate re-testing.
  • a further reason to compare the data on the carrier chip and the laboratory control system would be to compensate for the fact that the analyser performing the test may not be connected to the network of the laboratory control system. This can frequently be the case where equipment from different suppliers is incompatible with the installed laboratory control system. Comparing the data allows the information on the laboratory control system to be updated with the result of the test procedure.
  • a still further reason to load test results onto the chip is that the test results already performed on the sample are then readily available without reference to an external source, for example, if the sample is sent to another lab, or if the specimen is retrieved from storage for further testing.
  • sample carrier designed for use with a method as described above, which sample carrier comprises a base, side walls upwardly extending therefrom so as to define a lumen, the upper periphery of the side walls defining an opening through which a sample may be introduced into the lumen, and an addressable non-volatile memory chip attached to the base or side walls of the sample carrier and to which sample specific data may be stored and from which said data may be retrieved electronically using wireless transmission.
  • a resealable cap may be used temporarily to close the opening.
  • the memory chip may be integrally formed with the material of the sample carrier, for example by embedding therein during manufacture. Alternatively the memory chip may be permanently or removably attached to the sample carrier after manufacture.
  • the memory chip may preferably comprise a random access memory chip, connected to an aerial.
  • Sample carriers augmented with addressable memory chips according to the present invention would also allow the following functions to be developed as part of a fully automated system:
  • Robotic control mechanisms would be provided with radio frequency information from the microchip to assist accurate localisation of the sample carrier during manipulation; and, 2. Automated storage and retrieval systems for carriers that have completed testing. (Often clinicians request additional tests on samples that are already in the laboratory to save the necessity of taking another sample. Currently the laboratory technician has to retrieve the sample manually. Also different samples are kept in storage for variable lengths of time before being thrown away.)
  • the management of the storage system could be automated by having a robotic control system enhanced by a memory chip reader and instructed by the laboratory control system to locate the sample by detecting sample specific data.
  • a robotic control system enhanced by a memory chip reader and instructed by the laboratory control system to locate the sample by detecting sample specific data.
  • the system could detect all biochemistry samples in storage more than one week old and retrieve them for disposal.
  • a method of taking and labelling a sample from a patient comprising the steps of: - providing the patient with a identifying tag including an addressable non-volatile tagging chip to which patient data may be stored and from which said data may be retrieved electronically using wireless transmission;
  • Figure 1 is a flow chart of a simple embodiment of the present invention
  • Figure 2 is a flow chart of a different embodiment of the present invention wherein the lab system is linked to a networked user database
  • Figure 3 is a flow chart of a further embodiment of the present invention wherein the lab system is linked to a standalone user database;
  • Figure 4 is a flow chart of a yet further embodiment of the present invention wherein testing is carried out at the bedside;
  • Figures 5a, 5b and 5c show a sample being collected by a first sampling method
  • Figures 6a, 6b and 6c show a sample being collected by a second sampling method
  • Figures 7a and 7b show a sample being collected by a third sampling method.
  • a simplified flow diagram depicting a method according to the present invention is shown.
  • a sample 10 is loaded into a sample carrier 12 incorporating an addressable memory chip 14.
  • a lid 16 is placed on the open end of the sample carrier 12 to seal in the sample 10 and prevent contamination.
  • a personal digital assistant (PDA) 18 is used by a person taking the sample (the "sampler") or a person requesting the test (the "requestor" - who may also be the sampler), to program sample specific data on to the memory chip 14 using wireless transmission.
  • the personal digital assistant 18 may communicate with a personal computer 20 to transfer information.
  • the sample carrier 12 and contained sample 10 are then sent to a laboratory for appropriate testing.
  • the sample specific data held on the memory chip 14 is read and supplied to the laboratory's control system.
  • a laboratory identifying number or code is imparted to the memory chip to aid the tracking of the sample by the laboratory control system.
  • Appropriate testing procedures are then carried out on the sample either inside or outside the sample carrier.
  • the results of these tests, as well as the progress of the sample, are communicated to a database 22.
  • the database may form part of the laboratory control system or may be a separate central database. Indeed there need not be a database if the laboratory control system can supply the results directly back to the requestor. Not only are the results communicated back to the requestor, they are also loaded onto the memory chip 14.
  • test results on to the memory chip helps to ensure, along with the other information already stored thereon, that a sample carrier is capable of imparting to someone reading the chip all information necessary for testing and evaluation without reliance upon a separate database or network.
  • results recorded on the memory chip can be compared to results recorded in the database and discrepancies can be used to trigger appropriate re-testing or other diagnostic functions.
  • the carrier and sample contained therein may be disposed of or returned to the point of origin. Alternatively, it may be stored in case re- testing is needed.
  • the results may be returned to a requestor (or a requestor's personal digital assistant 18) by several means as already described herein.
  • the results are provided to the database, which in turn supplies them to either the personal computer 20 or the personal digital assistant 18 through an electronic delivery system 24.
  • This electronic delivery system would use locator information provided on the memory chip 14 to direct the results back to the requestor.
  • the results could be returned directly to the requestor or possibly could be supplied to a mailbox to which only the requestor has access. By accessing the mail box the requestor could therefore retrieve the results.
  • the system could operate using a network linking the equipment of the requestor and/or sampler to the laboratory systems as well as a central database (which could include a control/overseeing function).
  • a sample 10 is loaded into a carrier 12 incorporating a memory chip 14 which is programmed by a personal digital assistant 18, or a personal computer 30, incorporating a smart reader (or transponder) 32.
  • the personal digital assistant 18 and personal computer 30 are linked to a central database 34 either via a wireless or hard-wired LAN system.
  • the sample On receipt of the sample at the laboratory, the sample initially undergoes sample registration using a transponder 36 linked to the laboratory control system.
  • the laboratory control system then ensures suitable automated sample sorting and division and then controls the performance of appropriate tests on the sample.
  • the results are then communicated to the central database and loaded onto the chip 14. Once received by the central database the results are made available to the requestor by return to the personal digital assistant 18 or the personal computer 30.
  • the sample and sample carrier enter an automated storage and retrieval system.
  • This storage and retrieval system permits the requestor to initiate further tests simply by issuing suitable instructions and sending these to the laboratory system via the central database.
  • the laboratory control system may re-initiate appropriate testing and subsequently communicate the new results back to the requestor.
  • Such an automated storage and retrieval systems could also be used to dispose of samples in response to certain criteria such as age.
  • the method shown in Figure 3 is very similar to that described above in relation to Figure 2. However, it differs in that once the results are reported to the central database, the central database uses the locator information contained on the chip to return the results to a single non-networked machine.
  • the locator information could comprise the Internet protocol (IP) address of a requestor's computer 36 (e.g. a standalone PC in a doctor's surgery). In this way, the Internet could be utilised to return the results to a doctor who is not linked to a suitable private network.
  • IP Internet protocol
  • the main advantage of such a method is that, as long as all information is encoded on the sample carrier, before dispatch by the requestor, it is possible to return the results to the requestor without the need for a complicated network.
  • the requestor or doctor requires only a personal computer (or other suitable means such a wireless application protocol [WAP] telephone, laptop computer, personal digital assistant) with a transponder to program the information on to the memory chip.
  • the sample carrier and sample may then be forwarded by post or otherwise to a testing centre whereat the test results may be ascertained and provided to the central database.
  • the central database could then, using the locator information, return the results to the requestor. This would probably occur by providing the results in a central mailbox system, which the doctor could access via the Internet using the same or different device to the one which was used to program the chip.
  • FIG. 4 one particular method of local testing according to the present invention is shown.
  • a sample is loaded into a sample carrier with a program chip programmed in a similar way to that already described.
  • the sample and carrier are introduced to a bedside analyser 40. This reads the chip 14 and registers the sample before running the test.
  • the test results are stored on the memory chip 14 and are supplied to a requestor (or their personal digital assistant 18) directly - or through a central hospital database 42, possibly using a wireless LAN or networked personal computer 30 as previously described.
  • the samples may be subsequently forwarded to a full lab system where they are re-tested and a comparison is performed between results found in the lab against those on the memory chip 14.
  • the data from such near-patient analysis may be forwarded to the laboratory for final checking and authorisation before publication. This can allow verification or recalibrate (possibly remotely) of the bedside tester 40 to maintain accuracy.
  • 5b and 5c show a first method for secure loading of blood samples into a sample carrier for use in a method according to the present invention. Obviously this method could be adapted for other sampling, but sampling by venesection is exemplified because it is probably the most common sampling regime presently carried out in hospitals.
  • the patients are provided with personal tagging chips in addition to the usual hospital identity bracelet.
  • These tagging chips are usually very similar to the memory chips associated with the sample carriers and they contain patient specific data such as name, age, sex, date of birth, even basic medical details such as allergies etc.
  • a patient adhesive disk (plaster) 54 provided with a non-volatile tagging chip 56, is attached to the arm 50 by adhesive.
  • a personal digital assistant 58 with a wireless transponder, and in contact by wireless connection with a central network, is used to store patient specific data on the patient adhesive disk 54.
  • a requestor e.g. a doctor
  • a copy of the request may be relayed to a phlebotomist by wireless network.
  • the need for the test is therefore stored both on the patient adhesive disk, which a sampler can read independently, and on a task list supplied to the sampler directly (and verifiable by comparison to the tagging chip).
  • venesection blood sampling is commenced by inserting the needle 59 of a sampling device 60 such as a Vacutainer® into a vein 52 near the patient adhesive disk 54.
  • a sampling device 60 such as a Vacutainer®
  • the sampling device is modified to include a transponder 61 , capable of reading the patient adhesive disk 54.
  • a sample carrier 62 incorporating a memory chip 64, and with a partial vacuum therein, is introduced in to the sampling device and blood is drawn therein (best shown in Figure 5C) by know techniques.
  • the transponder then reads the patient specific data from the patient adhesive disk 54 and loads it on to the memory chip 64 of the sample carrier 62.
  • the transponder also writes the remainder of the sample specific data to the memory chip so that sample and sample carrier are ready for transfer to the test environment.
  • This simultaneous labelling of the carrier with data while introducing blood directly from the patient into the carrier offers the most secure means of associating patient identifying data with the carrier and sample.
  • FIG. 6a - 6c A similar method is shown in Figures 6a - 6c.
  • This method differs in that the patient specific data is held on a tagging chip incorporated in a bracelet 66. This prevents the simultaneous reading of the patient data and writing to the memory chip due to the incompatible positioning. Therefore the method is altered in that the patient specific data is read by the transponder 61 ( Figure 6b) before taking of the sample ( Figure 6c), and is stored on the personal digital assistant 58 before transfer to the memory chip whilst the sample carrier is contained in the sampling device.
  • FIGs 7a and 7b a third method for secure labelling of blood samples during venesections is shown.
  • patient specific data is stored on a bracelet 66 as already described.
  • a conventional syringe 68 is used to draw blood from a vein 52.
  • the patient specific data is read from the tagging chip 56 by a personal digital assistant 58, and stored thereon.
  • the blood sample obtained using the syringe 68 is, as shown in Figure
  • sample 7b deposited into a sample carrier 62 with a memory chip 64.
  • the sample specific data (including the patient specific data obtained from the tagging chip 56) is then loaded on to the memory chip 64.
  • the sample, and indeed any of the samples taken by the methods shown in Figure 5 or 6 are then sent to a testing environment and the results returned as already described.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Automation & Control Theory (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

L'invention concerne un procédé destiné à la poursuite et au contrôle du passage d'échantillons dans des procédures d'analyse, consistant à introduire un échantillon (10) dans un support d'échantillon (12) équipé d'une puce mémoire (14) permettant d'enregistrer et de fournir des données pouvant être récupérées par technique sans fil, à programmer des données spécifiques à l'échantillon, telles que la provenance de l'échantillon et les analyses à effectuer, sur la puce (14), à introduire le support d'échantillon et l'échantillon dans un appareil d'analyse avec un dispositif de lecture de puce, puis à lire électroniquement les données sur la puce (14), à effectuer le traitement et le tri appropriés sur l'échantillon, à charger au moins des détails partiels concernant les analyses effectuées sur la puce mémoire (14) et, finalement, à utiliser les données spécifiques à l'échantillon pour renvoyer les résultats de l'analyse et d'autres données à une personne ayant demandé cette analyse. L'invention concerne également des supports d'échantillon destinés à être utilisés dans ce procédé.
PCT/GB2001/005578 2000-12-16 2001-12-17 Systemes de poursuite d'echantillons Ceased WO2002056121A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001297886A AU2001297886A1 (en) 2000-12-16 2001-12-17 Sample tracking systems

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0030809.8A GB0030809D0 (en) 2000-12-16 2000-12-16 Sample tracking systems
GB0030809.8 2000-12-16

Publications (2)

Publication Number Publication Date
WO2002056121A2 true WO2002056121A2 (fr) 2002-07-18
WO2002056121A3 WO2002056121A3 (fr) 2002-12-05

Family

ID=9905292

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/005578 Ceased WO2002056121A2 (fr) 2000-12-16 2001-12-17 Systemes de poursuite d'echantillons

Country Status (3)

Country Link
AU (1) AU2001297886A1 (fr)
GB (1) GB0030809D0 (fr)
WO (1) WO2002056121A2 (fr)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004347376A (ja) * 2003-05-20 2004-12-09 Techno Medica Co Ltd 採血管準備システム
EP1564648A3 (fr) * 2004-02-14 2006-05-24 Universitätsklinikum Düsseldorf Anstalt des öffentlichen Rechts Procédé de surveillance d'échantillons de laboratoire
US7400983B2 (en) 2002-12-20 2008-07-15 Dako Denmark A/S Information notification sample processing system and methods of biological slide processing
JP2008224385A (ja) * 2007-03-12 2008-09-25 Olympus Corp 分析装置および分析方法
JP2009002959A (ja) * 2008-08-07 2009-01-08 Nipro Corp 検体検査システム
US7584019B2 (en) 2003-12-15 2009-09-01 Dako Denmark A/S Systems and methods for the automated pre-treatment and processing of biological samples
US7850912B2 (en) 2003-05-14 2010-12-14 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US7860727B2 (en) 2003-07-17 2010-12-28 Ventana Medical Systems, Inc. Laboratory instrumentation information management and control network
US7867443B2 (en) 2004-07-23 2011-01-11 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US7875245B2 (en) 2003-05-14 2011-01-25 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
WO2011107571A1 (fr) * 2010-03-05 2011-09-09 B. Braun Melsungen Ag Système et procédé de surveillance d'au moins un paramètre sanguin
EP1771716A4 (fr) * 2004-06-29 2012-04-25 Dako Denmark As Procede de pretraitement et de coloration d'echantillon biologique et support pour cet echantillon
JP2013130398A (ja) * 2011-12-20 2013-07-04 Taketomo:Kk 検体管理システム
JP2013210266A (ja) * 2012-03-30 2013-10-10 Sysmex Corp 検体処理装置、検体分析装置、検体分析システム、検体処理システムおよび検体処理方法
US8719053B2 (en) 2003-07-17 2014-05-06 Ventana Medical Systems, Inc. Laboratory instrumentation information management and control network
US9117024B2 (en) 2001-11-13 2015-08-25 Dako Denmark A/S System for tracking biological samples
WO2015194001A1 (fr) * 2014-06-19 2015-12-23 ホクユーメディックス株式会社 Système de gestion de tube de collecte de sang
US9767425B2 (en) 2008-02-29 2017-09-19 Dako Denmark A/S Systems and methods for tracking and providing workflow information
WO2018091990A1 (fr) * 2016-11-18 2018-05-24 Biobox Dispositif de suivi d'un échantillon biologique notamment en vue d'une analyse en laboratoire

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2556772A1 (fr) 2004-03-02 2005-09-15 Dako Denmark A/S Systeme de distribution de reactifs, dispositif de distribution et contenant pour un appareil de coloration biologique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3656473A (en) * 1969-08-28 1972-04-18 American Science & Eng Inc Medical data processing
US5525304A (en) * 1994-06-24 1996-06-11 Pasteur Sanofi Diagnostics Apparatus for automated chemical analysis with variable reagents
DE19621179C2 (de) * 1996-05-25 2000-09-07 Nonnenmacher Klaus Transporteinheit für Proben
JP3493910B2 (ja) * 1996-08-23 2004-02-03 株式会社日立製作所 自動化処理システム

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9117024B2 (en) 2001-11-13 2015-08-25 Dako Denmark A/S System for tracking biological samples
US9659153B2 (en) 2001-11-13 2017-05-23 Dako Denmark A/S System for tracking biological samples
US7937228B2 (en) 2002-12-20 2011-05-03 Dako Denmark A/S Information notification sample processing system and methods of biological slide processing
US8969086B2 (en) 2002-12-20 2015-03-03 Dako Denmark A/S Enhanced scheduling sample processing system and methods of biological slide processing
US7400983B2 (en) 2002-12-20 2008-07-15 Dako Denmark A/S Information notification sample processing system and methods of biological slide processing
US9599630B2 (en) 2002-12-20 2017-03-21 Dako Denmark A/S Method and apparatus for automatic staining of tissue samples
US9229016B2 (en) 2002-12-20 2016-01-05 Dako Denmark A/S Information notification sample processing system and methods of biological slide processing
US9182324B2 (en) 2002-12-20 2015-11-10 Dako Denmark A/S Systems and methods for the automated pre-treatment and processing of biological samples
US10156580B2 (en) 2002-12-20 2018-12-18 Dako Denmark A/S Information notification sample processing system and methods of biological slide processing
US8386195B2 (en) 2002-12-20 2013-02-26 Dako Denmark A/S Information notification sample processing system and methods of biological slide processing
US8663978B2 (en) 2002-12-20 2014-03-04 Dako Denmark A/S Method and apparatus for automatic staining of tissue samples
US8673642B2 (en) 2002-12-20 2014-03-18 Dako Denmark A/S Enhanced scheduling sample processing system and methods of biological slide processing
US9778273B2 (en) 2002-12-20 2017-10-03 Dako Denmark A/S Isolated communication sample processing system and methods of biological slide processing
US8394635B2 (en) 2002-12-20 2013-03-12 Dako Denmark A/S Enhanced scheduling sample processing system and methods of biological slide processing
US7960178B2 (en) 2002-12-20 2011-06-14 Dako Denmark A/S Enhanced scheduling sample processing system and methods of biological slide processing
US8788217B2 (en) 2002-12-20 2014-07-22 Dako Denmark A/S Information notification sample processing system and methods of biological slide processing
US7875245B2 (en) 2003-05-14 2011-01-25 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US7850912B2 (en) 2003-05-14 2010-12-14 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
JP2004347376A (ja) * 2003-05-20 2004-12-09 Techno Medica Co Ltd 採血管準備システム
US7860727B2 (en) 2003-07-17 2010-12-28 Ventana Medical Systems, Inc. Laboratory instrumentation information management and control network
US8719053B2 (en) 2003-07-17 2014-05-06 Ventana Medical Systems, Inc. Laboratory instrumentation information management and control network
US8812329B2 (en) 2003-07-17 2014-08-19 Ventana Medical Systems, Inc. Laboratory instrumentation information management and control network
US7603201B2 (en) 2003-12-08 2009-10-13 Dako Denmark A/S Systems and methods for the automated pre-treatment and processing of biological samples
US7584019B2 (en) 2003-12-15 2009-09-01 Dako Denmark A/S Systems and methods for the automated pre-treatment and processing of biological samples
EP1564648A3 (fr) * 2004-02-14 2006-05-24 Universitätsklinikum Düsseldorf Anstalt des öffentlichen Rechts Procédé de surveillance d'échantillons de laboratoire
US8283176B2 (en) 2004-06-29 2012-10-09 Dako Denmark A/S Method of pre-treatment and staining of a biological sample and device for support of a biological sample and methods of using such device
EP1771716A4 (fr) * 2004-06-29 2012-04-25 Dako Denmark As Procede de pretraitement et de coloration d'echantillon biologique et support pour cet echantillon
US7867443B2 (en) 2004-07-23 2011-01-11 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US7593787B2 (en) 2005-07-07 2009-09-22 Dako Denmark A/S Systems and methods for the automated pre-treatment and processing of biological samples
WO2008126589A1 (fr) * 2007-03-12 2008-10-23 Olympus Corporation Dispositif d'analyse et procédé d'analyse
JP2008224385A (ja) * 2007-03-12 2008-09-25 Olympus Corp 分析装置および分析方法
US9767425B2 (en) 2008-02-29 2017-09-19 Dako Denmark A/S Systems and methods for tracking and providing workflow information
US10832199B2 (en) 2008-02-29 2020-11-10 Agilent Technologies, Inc. Systems and methods for tracking and providing workflow information
JP2009002959A (ja) * 2008-08-07 2009-01-08 Nipro Corp 検体検査システム
WO2011107571A1 (fr) * 2010-03-05 2011-09-09 B. Braun Melsungen Ag Système et procédé de surveillance d'au moins un paramètre sanguin
JP2013517030A (ja) * 2010-03-05 2013-05-16 ベー．ブラウン メルズンゲン アーゲー 少なくとも１つの血液パラメータをモニタリングするシステム及び方法
JP2013130398A (ja) * 2011-12-20 2013-07-04 Taketomo:Kk 検体管理システム
JP2013210266A (ja) * 2012-03-30 2013-10-10 Sysmex Corp 検体処理装置、検体分析装置、検体分析システム、検体処理システムおよび検体処理方法
WO2015194001A1 (fr) * 2014-06-19 2015-12-23 ホクユーメディックス株式会社 Système de gestion de tube de collecte de sang
WO2018091990A1 (fr) * 2016-11-18 2018-05-24 Biobox Dispositif de suivi d'un échantillon biologique notamment en vue d'une analyse en laboratoire

Also Published As

Publication number Publication date
AU2001297886A1 (en) 2002-07-24
WO2002056121A3 (fr) 2002-12-05
GB0030809D0 (en) 2001-01-31

Similar Documents

Publication Publication Date Title
WO2002056121A2 (fr) Systemes de poursuite d'echantillons
US20040267562A1 (en) Method for taking a sample from a system
US20200351094A1 (en) Biosignature-based tokenization of assets in a blockchain
US20100088116A1 (en) Specimen tracking and management verification
US20100063847A1 (en) Rule-driven specimen tracking and management
MXPA06012551A (es) Sistema y aparato para controlar errores medicos.
US20100127067A1 (en) Print device for specimen tracking and management
US20070036686A1 (en) Systems for tracking and testing of medical specimens and data
US20150339438A1 (en) Analysis system and computer implemented method for analyzing biological samples
JP2012514201A (ja) 組織病理学のために組織サンプルを処理するためのシステム及び方法
WO2008156566A1 (fr) Réseau de gestion et de contrôle d'informations d'instrumentation de laboratoire
EP2130161A1 (fr) Dépistage et gestion des spécimens
US20140081657A1 (en) Apparatus and Methods for Storage and Transfer of Patient Information Using Biological Sample Cards with Short Range Communications
US8822224B2 (en) Method for automatic testing of anatomical laboratory specimens
US12141752B2 (en) Intelligent routing of radio-frequency identification data
CN104854591A (zh) 用于使用具有短程通信的生物样本卡存储和传送患者信息的设备和方法
US20180268924A1 (en) Methods for laboratory sample tracking and devices thereof
EP4189692A1 (fr) Gestion préanalytique de paramètres de récipient d'échantillon
WO2024038370A1 (fr) Désidentification sélective de données
JP2019095868A (ja) 健康医療介護連携システムのデータ連携方法、データ連携用プログラム、および、健康医療介護連携システム用のサーバ
GB2597686A (en) Pre-analytic management of sample container parameters
KR101500331B1 (ko) 채혈실 자동접수 및 검체 관리시스템 및 그 방법
JP4668449B2 (ja) 検査情報デ−タセンター及び検査情報データ変換方法
Eminaga et al. An electronic specimen collection protocol Schema (eSCPS)
US20240296921A1 (en) Computer-implemented method in the field of clinical tests of biological samples

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP